updates in recurrent/metastatic nasopharyngeal carcinoma: the role of immune checkpoint inhibitors
Published 1 month ago • 78 plays • Length 17:24Download video MP4
Download video MP3
Similar videos
-
33:50
immunotherapy for recurrent or metastatic hnscc: what are the practical considerations?
-
12:48
impact of immune checkpoint inhibitors
-
16:00
reducing the lifespan of nasopharynx cancer cells | dr. nethia mohana kumaran | tedxusmnibongtebal
-
3:29:11
management of recurrent nasopharyngeal cancers webinar
-
13:15
nasopharyngeal carcinoma (npc): location, risk factors, clinical picture, diagnosis& management
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
6:07
sequential use of immune checkpoint inhibitors in renal cell carcinoma
-
2:44
nasopharyngeal carcinoma, causes, signs and symptoms, diagnosis and treatment.
-
3:14
treatments for head and neck cancer (squamous carcinoma tumor)
-
5:33
cancer immune checkpoint inhibitors
-
1:00:44
targeting cancer pathways: understanding immune checkpoints
-
0:58
what are immune checkpoints?
-
2:40
the current role of checkpoint inhibitors in head and neck cancer
-
2:08
research investigates role of antiangiogenic agents and checkpoint inhibitors in egfr nsclc
-
2:34
biomarkers of response to checkpoint inhibitors in untreated mnsclc
-
3:55
checkpoint inhibitors for recurrent hnscc
-
13:37
e49 – immune checkpoint inhibitors
-
3:51
checkpoint inhibitors in hnscc
-
0:56
checkpoint inhibitors for lung cancer treatment
-
22:49
managing side effects of checkpoint inhibitors
-
1:53
new treatment approaches for merkel cell carcinoma - checkpoint inhibitors